Skip to main content
. 2017 Jul 10;30(4):283–289. doi: 10.1293/tox.2017-0029

Fig. 4.

Fig. 4.

Phospho-histone H3-positive cells in spermatogonia and spermatocytes after 96 h MTX treatment. A. Control wild-type medaka group. B. MTX-treated wild-type medaka group. C. Control homogenic p53-deficient (p53 (−/−)) medaka group. D. MTX-treated homogenic p53-deficient (p53 (−/−)) medaka group. Bar = 30 μm.